HEMACEUTICAL Trademark

Trademark Overview


On Tuesday, January 4, 2022, a trademark application was filed for HEMACEUTICAL with the United States Patent and Trademark Office. The USPTO has given the HEMACEUTICAL trademark a serial number of 97202507. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, February 27, 2024. This trademark is owned by New York Blood Center, Inc.. The HEMACEUTICAL trademark is filed in the Pharmaceutical Products, Insurance & Financial Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical cord blood preparations for autologous transplantation, allogeneic transplantation, and human transplant uses

Venture capital fund management; venture capital advisory services; venture capital services, namely, providing financing to emerging and start-up companies; investment management

Blood bank services; tissue bank services; collection and preservation of human blood, red blood cells, plasma and bone marrow; collection and preservation of human blood, red blood cells, plasma and bone

Biomedical research and development services in the field of transfusion medicine, regenerative medicine and cellular therapy related research and clinical programs from discovery through development and to the clinic
hemaceutical

General Information


Serial Number97202507
Word MarkHEMACEUTICAL
Filing DateTuesday, January 4, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, February 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements


Goods and ServicesPharmaceutical cord blood preparations for autologous transplantation, allogeneic transplantation, and human transplant uses
Goods and ServicesVenture capital fund management; venture capital advisory services; venture capital services, namely, providing financing to emerging and start-up companies; investment management
Goods and ServicesBlood bank services; tissue bank services; collection and preservation of human blood, red blood cells, plasma and bone marrow; collection and preservation of human blood, red blood cells, plasma and bone
Goods and ServicesBiomedical research and development services in the field of transfusion medicine, regenerative medicine and cellular therapy related research and clinical programs from discovery through development and to the clinic

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, January 8, 2022
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, January 8, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, January 8, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNew York Blood Center, Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNew York, NY 10065

Party NameNew York Blood Center, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew York, NY 10065

Trademark Events


Event DateEvent Description
Friday, January 7, 2022NEW APPLICATION ENTERED
Saturday, January 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 7, 2022ASSIGNED TO EXAMINER
Friday, October 7, 2022NON-FINAL ACTION WRITTEN
Friday, October 7, 2022NON-FINAL ACTION E-MAILED
Friday, October 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 5, 2022NON-FINAL ACTION WRITTEN
Monday, December 5, 2022NON-FINAL ACTION E-MAILED
Monday, December 5, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 12, 2023NON-FINAL ACTION WRITTEN
Thursday, January 12, 2023NON-FINAL ACTION E-MAILED
Thursday, January 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 18, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 18, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 18, 2023SOU EXTENSION 1 FILED
Friday, August 18, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 18, 2023SOU EXTENSION 1 GRANTED
Tuesday, February 27, 2024SOU EXTENSION 2 FILED
Tuesday, February 27, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 27, 2024SOU EXTENSION 2 GRANTED
Wednesday, February 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 13, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, August 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 31, 2023ASSIGNED TO EXAMINER